HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Initial experiences with the HeartMate vented electric left ventricular assist system in Japan.

Abstract
We report three consecutive cases of long-term circulatory support using the HeartMate vented electric (VE) left ventricular assist system (LVAS). The HeartMate VE LVAS dramatically improved the functional status and quality of life of these three patients with end-stage heart failure, and all were successfully bridged to transplantation after 659, 995, and 1055 days of support on the device. Only an antiplatelet agent was used for anticoagulation therapy, and no cerebrovascular event occurred. Although the pump stopped in two of these three patients 665 days and 491 days after implantation, both were supported by the backup pneumatic driver thereafter. The drive-line exit site became infected in one patient and thinning of the left ventricular wall due to an unknown cause occurred in one patient.
AuthorsShunsuke Saito, Takeshi Nakatani, Kazuo Niwaya, Junjiro Kobayashi, Akihisa Hanatani, Osamu Tagusari, Hiroyuki Nakajima, Kunio Miyatake, Toshikatsu Yagihara, Soichiro Kitamura
JournalJournal of artificial organs : the official journal of the Japanese Society for Artificial Organs (J Artif Organs) Vol. 10 Issue 2 Pg. 118-21 ( 2007) ISSN: 1434-7229 [Print] Japan
PMID17574516 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Heart Failure (surgery)
  • Heart Transplantation
  • Heart-Assist Devices
  • Humans
  • Male
  • Middle Aged
  • Prosthesis Implantation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: